Summary
- Current Price
- As of today, INO price is $1.13, down -35.06% on
- Current Price All-Time High
- INO price is currently -99.95% below its historical high of $2,352.00 set on
- Market Cap
- INO current market cap is $78M, up +27.52% over the past 365 days
- PE Ratio
- INO PE ratio is unknown
- Revenue
- INO current annual revenue is $65.30K, down -70.02% year-over-year
- Next Earnings
- The next earnings release for INO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Inovio Pharmaceuticals, Inc. |
| Ticker | NASDAQ: INO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inovio.com |
| Employees | 134 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.13 | ||
| Price, 1D Change | -35.06% | |
| $78M | ||
| - | ||
| - | ||
| 0.97 | ||
| $65K | ||
| Revenue, 1Y Change | -70.02% | |
| -$1.81 | ||
| EPS, 1Y Change | +54.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GEB | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.81 | ||
| EPS Estimate | N/A | -$1.12 |
| EPS Est. Change | N/A | +38.04% |
| $65.30K | ||
| Revenue Estimate | N/A | $10.39M |
| Revenue Est. Change | N/A | +15,806.85% |
| $1.13 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +607.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.21 | -$3.95 | +6.20% | |
| -$2.34 | -$1.81 | +22.49% | |
| -$1.12 | N/A | +38.04% | |
| -$0.65 | N/A | +64.30% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $125.33K | $217.80K | +73.78% | |
| $88.33K | $65.30K | -26.07% | |
| $10.39M | N/A | +15,806.85% | |
| $68.40M | N/A | +104,646.94% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -31.93% | ||
| -88.52% | ||
| +27.52% | ||
| -63.97% | ||
| -70.02% | ||
| -99.36% | ||
| +54.12% | ||
| +87.13% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.13 | ||
| $1.93 | ||
| SMA 200 vs Price | +70.44% | |
| $1.65 | ||
| SMA 50 vs Price | +46.30% | |
| 0.97 | ||
| $0.13 | ||
| 25.88 | ||
| 184.92% | ||
| 88.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $65.30K | ||
| -$1.81 | ||
| -$2.92M | ||
| -4,477.03% | ||
| -$86.82M | ||
| -132.96% | ||
| -$84.95M | ||
| -130.09% | ||
| -$83.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.39 | ||
| 1.40 | ||
| 1.40 | ||
| - | ||
| - | ||
| -36.18 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1,188.89 | ||
| 3.22 | ||
| -0.34 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $24.10M | ||
| $58.51M | ||
| $75.68M | ||
| $61.12M | ||
| $51.59M | ||
| $43.67M | ||
| $9.37M | ||
| $2.82M | ||
| $2.62M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $85.01M | ||
| $83.90M | ||
| $2.99M | ||
| $0.00 | ||
| $2.99M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$88.63M | ||
| $14.04M | ||
| $53.05M | ||
| $285.70K | ||
| -$88.92M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | ||
| RBC Capital | → | |
| Oppenheimer | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with INO
FAQ
What is the ticker symbol for Inovio Pharmaceuticals, Inc.?
The ticker symbol for Inovio Pharmaceuticals, Inc. is NASDAQ:INO
Does Inovio Pharmaceuticals, Inc. pay dividends?
No, Inovio Pharmaceuticals, Inc. does not pay dividends
What sector is Inovio Pharmaceuticals, Inc. in?
Inovio Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Inovio Pharmaceuticals, Inc. in?
Inovio Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Inovio Pharmaceuticals, Inc. based in?
Inovio Pharmaceuticals, Inc. is headquartered in United States
When did Inovio Pharmaceuticals, Inc. go public?
Inovio Pharmaceuticals, Inc. initial public offering (IPO) was on December 8, 1998
Is Inovio Pharmaceuticals, Inc. in the S&P 500?
No, Inovio Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Inovio Pharmaceuticals, Inc. in the NASDAQ 100?
No, Inovio Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Inovio Pharmaceuticals, Inc. in the Dow Jones?
No, Inovio Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Inovio Pharmaceuticals, Inc. last earnings report?
Inovio Pharmaceuticals, Inc.'s most recent earnings report was on March 12, 2026
When does Inovio Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Inovio Pharmaceuticals, Inc. is May 13, 2026
Data Sources & References
- INO Official Website www.inovio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1055726/000105572626000008/0001055726-26-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1055726/000105572626000008/0001055726-26-000008-index.htm
- INO Profile on Yahoo Finance finance.yahoo.com/quote/INO
- INO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ino